ITCI - Intra-Cellular Kompaniya qiymatining foyda o‘sish sur’atiga nisbati
Intra-Cellular Therapies (ITCI) shizofreniyani davolash uchun mo‘ljallangan innovatsion Caplyta dori vositasi orqali shifokorlarning ishonchini qozongan neyrofarmatsevtika sohasining taniqli yetakchisidir. GURU.Markets grafigidagi o‘sishga yo‘naltirilgan P/E ko‘rsatkichi o‘zgaruvchan kutishlarni aks ettirmoqda va joriy parametr 0.00 darajasida turibdi. Dori vositalarini ishlab chiqish robotlashtirilgan hujayra monitoringi orqali tezlashmoqda, barqaror neyrobiologlar shtati esa tijorat vakillarini faol ishga olish orqali kengaytirilmoqda.
Intra-Cellular Therapies (ITCI) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi haqida ma'lumot:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Intra-Cellular Therapies|ITCI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati intracellulartherapies.com|ITCI - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Intra-Cellular|ITCI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Intra-Cellular Therapies|Tezkor likvidlik intracellulartherapies.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ITCI - Sof daromad|Prognoz qilingan kelajakdagi foyda Intra-Cellular Therapies|ITCI - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati intracellulartherapies.com|ITCI - PEG multiplikatori|EV/EBITDA multiplikatori Intra-Cellular|ITCI - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Intra-Cellular Therapies|ITCI - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi intracellulartherapies.com|ITCI - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Intra-Cellular Therapies
Kompaniyaning umumiy tahlili:ITCI - Intra-Cellular Therapies Inc.
PEG koeffitsiyenti joriy P/E ko'rsatkichini foyda o'sish sur'atlari bilan solishtirish orqali aktivlar sifati va baholash o'rtasidagi muvozanatni topish uchun ishlatiladi hamda qiymat birdan past bo'lganda past baholangan biznesni aniqlaydi. Intra-Cellular Therapies (ITCI) holatida, kuchli narx belgilash imkoniyati va dori vositasiga bo'lgan barqaror talab o'sishga moslashtirilgan P/E koeffitsiyentini kompaniyaning kapitalizatsiya yetarliligining asosiy ko'rsatkichiga aylantiradi.
Intra-Cellular Therapies raqobatchilari
Biogen Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati RGC (Regencell Corp)|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACAD (acadia-pharm.com)|XENE: PEG multiplikatori|Viking Therapeutics Inc (VKTX) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori SUPN|CPRX - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori DNLI|Narx-foyda va o‘sish multiplikatori harmonybiosciences.com HRMY|PEG multiplikatori BHVN (Biohaven)|Amylyx Pharmaceuticals Inc (AMLX) - O‘sish sur’atiga tuzatilgan narx-foyda|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|PRAX: Narxning foydaga va o‘sish sur’atiga nisbati|Anavex Life Sciences (AVXL) - Narxning foydaga va o‘sish sur’atiga nisbati|CBLL (ceribell.com) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori PRTA|PEG multiplikatori Alector Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|Narxning foydaga va o‘sish sur’atiga nisbati OMER (omeros.com)|PEG multiplikatori NGNE (Neurogene Inc.)|PEG multiplikatori acimmune.com ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti NMRA (Neumora)|SCLX (Scilex Holding Co.) - Narx-foyda va o‘sish multiplikatori|Tevogen Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori ACOG|CGTX (cogrx.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori IKT|SAVA (Cassava Sciences Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ASRT (Assertio)|Coya Therapeutics Inc (COYA) - O‘sish sur’atiga tuzatilgan narx-foyda|VTGN - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti OVID (Ovid Therapeutics Inc.)|ABOS: PEG multiplikatori|CervoMed, Inc. (CRVO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Ltd.|Clene Nanomedicine - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori PEPG|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati jupiterneurosciences.com|PEG multiplikatori RLMD (Relmada Therapeutics, Inc.)|Annovis Bio Inc (ANVS) - O‘sish sur’atiga tuzatilgan narx-foyda|GRCE - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Firefly Neuro AIFF|KLTO: PEG multiplikatori|NRSN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori RVPH|MTVA (MetaVia, Inc.) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori NRXS|Narx-foyda va o‘sish multiplikatori heliusmedical.com HSDT|PEG multiplikatori PASG (Passage Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neuphoria Therapeutics, Inc. (NEUP)|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|ATHA (Athira Pharma Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ADXN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Alzamend Neuro (ALZN)|Narx-foyda va o‘sish multiplikatori CYCN|PEG multiplikatori Protagenic|Narxning foydaga va o‘sish sur’atiga nisbati Pasithea Therapeutics (KTTA)|CRGT (cortigent.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Avenue Therapeutics, Inc ATXI|BrainStorm Cell Therapeutics Inc. (BCLI) - O‘sish sur’atiga tuzatilgan narx-foyda|Cara Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati chromocell.com CHRO|eliemtx.com (ELYM) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti LBPH|Narx-foyda va o‘sish multiplikatori MRNS|NKGN (NKGen Biotech Corp) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SNPX (Synaptogenix)|PEG multiplikatori Trevena Inc. TRVN|VIGL: Narx-foyda va o‘sish multiplikatori|Narxning sof foyda o‘sishiga nisbati Anew Medical Inc. (WENA)|CERE: PEG multiplikatori
